Vágner Adrienn

1.

Ngo, M. T., Vágner, A., Nagy, G., Ország, G., Nagy, T., Szoboszlai, Z., Csikos, C., Váradi, B., Trencsényi, G., Tircsó, G., Garai, I.: HER2 expression in different cell lines at different inoculation sites assessed by [52Mn]Mn-DOTAGA(anhydride)-trastuzumab.
Pathol. Oncol. Res. 31, 1-12, (article identifier: 1611999), 2025.

doi DEA WoS Scopus

Journal metrics:

Q3 Cancer Research (2024)

Q2 Medicine (miscellaneous) (2024)

Q2 Oncology (2024)

Q2 Pathology and Forensic Medicine (2024)

2.

Ngo, M. T., Vágner, A., Nagy, G., Ország, G., Nagy, T. M., Csikos, C., Váradi, B., Sajtos, G. Z., Kapus, I., Szoboszlai, Z., Szikra, D. P., Trencsényi, G., Tircsó, G., Garai, I.: [52 Mn]Mn-BPPA-Trastuzumab: A Promising HER2-Specific PET Radiotracer.
J. Med. Chem. 67 (10), 8261-8270, 2024.

doi DEA WoS Scopus

Journal metrics:

D1 Drug Discovery

Q1 Molecular Medicine

3.

Martinelli, J., Zapelli, L. M., Boccalon, M., Vágner, A., Nagy, G., Fekete, A., Szikra, D. P., Trencsényi, G., Baranyai, Z., Tei, L.: AAZTA-like ligands bearing phenolate arms as efficient chelators for 68Ga labelling in vitro and in vivo.
Chem.-Eur. J. 29 (21), 1-11, (article identifier: 202203798), 2023.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Chemistry (miscellaneous)

Q1 Organic Chemistry

4.

Csikos, C., Képes, Z., Fekete, A., Vágner, A., Nagy, G., Gyuricza, B., Arató, V. Z., Kárpáti, L., Mándity, I. M., Bruchertseifer, F., Halmos, G., Szikra, D. P., Trencsényi, G.: Evaluation of the therapeutic efficacy of 213Bi-labelled DOTA-conjugated alpha-melanocyte stimulating hormone peptide analogues in melanocortin-1 receptor positive preclinical melanoma model.
Int. J. Pharm. 644, 1-9, (article identifier: 123344), 2023.

doi DEA Scopus

Journal metrics:

Q1 Pharmaceutical Science

5.

Kálmán-Szabó, I., Képes, Z., Fekete, A., Vágner, A., Nagy, G., Szűcs, D., Gyuricza, B., Arató, V. Z., Varga, J., Kárpáti, L., Garai, I., Mándity, I. M., Bruchertseifer, F., Elek, J., Szikra, D. P., Trencsényi, G.: In Vivo evaluation of newly synthesized 213Bi-conjugated alpha-melanocyte stimulating hormone (α-MSH) peptide analogues in melanocortin-1 receptor (MC1-R) positive experimental melanoma model.
J. Pharm. Biomed. Anal. 229, 1-9, (article identifier: 115374), 2023.

doi DEA WoS Scopus

Journal metrics:

Q2 Analytical Chemistry

Q2 Clinical Biochemistry

Q2 Drug Discovery

Q2 Pharmaceutical Science

Q2 Spectroscopy

6.

Váradi, B., Brezovcsik, K., Garda, Z., Madarasi, E., Szedlacsek, H., Badea, R. A., Vasilescu, A. M., Puiu, A. G., Ionescu, A. E., Sima, L. E., Munteanu, C. V. A., Cǎlǎraş, S., Vágner, A., Szikra, D. P., Ngo, M. T., Nagy, T., Szűcs, Z., Szedlacsek, S. E., Nagy, G., Tircsó, G.: Synthesis and characterization of a novel [52Mn]Mn-labelled affibody based radiotracer for HER2+ targeting.
Inorg. Chem. Front. 10 (16), 4734-4745, 2023.

doi DEA WoS Scopus

Journal metrics:

D1 Inorganic Chemistry

7.

Horváth, D., Vágner, A., Szikra, D. P., Trencsényi, G., Demitri, N., Guidolin, N., Maiocchi, A., Ghiani, S., Travagin, F., Giovenzana, G. B., Baranyai, Z.: Boosting Bismuth(III) Complexation for Targeted [alfa]-Therapy (TAT) Applications with the Mesocyclic Chelating Agent AAZTA.
Angew. Chem.-Int. Edit. 61 (43), 1-9, 2022.

doi DEA WoS Scopus

Journal metrics:

D1 Catalysis

D1 Chemistry (miscellaneous)

8.

Vágner, A., Ngo, M. T., Nagy, G., Nagy, T., Sajtos, G. Z., Váradi, B., Szikra, D. P., Tircsó, G., Garai, I.: In vivo imaging of HER2 receptor status with a novel Mn-52-labelled antibody.
Eur. J. Nucl. Med. Mol. Imaging. 49 (SUPPL1), S282-S282, 2022.

DEA WoS

9.

Váradi, B., Garda, Z., Madarasi, E., Brezovcsik, K., Vágner, A., Nagy, T., Garai, I., Ngo, M. T., Puiu, A. G., Vasilescu, A. M., Szűcs, Z., Szedlacsek, S. E., Nagy, G., Tircsó, G.: Labelling anti-HER2-affibodies with Mn-52 via pyclen based bifunctional ligands: from ligand design to in vivo PET/MR experiments.
Eur. J. Nucl. Med. Mol. Imaging. 49 (SUPPL1), S283-S283, 2022.

DEA WoS

10.

Szűcs, D., Csupász, T., Péli-Szabó, J., Kis, A., Gyuricza, B., Arató, V. Z., Forgács, V., Vágner, A., Nagy, G., Garai, I., Szikra, D. P., Tóth, I., Trencsényi, G., Tircsó, G., Fekete, A.: Synthesis, physicochemical, labeling and in vivo characterization of a DO3AM-based hypoxia sensitive 44Sc-labeled PET probe.
Pharmaceuticals (Basel). 15 (6), 1-16, (article identifier: 666), 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Drug Discovery

Q2 Molecular Medicine

Q1 Pharmaceutical Science

11.

Gyuricza, B., Péli-Szabó, J., Arató, V. Z., Szűcs, D., Vágner, A., Szikra, D. P., Fekete, A.: 68Ga jelzett kettős targetálású glikopeptid alapú radiofarmakon szintézise.
In: Őszi Radiokémiai napok 2021. Szerk.: Jószai István, Magyar Kémikusok Egyesülete, Budapest, 39-44, 2021. ISBN: 9786156018076

DEA

12.

Gyuricza, B., Péli-Szabó, J., Arató, V. Z., Szűcs, D., Vágner, A., Szikra, D. P., Fekete, A.: 68GA-NODAGA-LACN-E[C(RGDFK)]2 glikopeptid alapú radiofarmakon szintézise.
In: II. Fiatal Kémikusok Fóruma Szipózium Absztraktfüzet. Szerk.: Bodor Zsanett, Ádám Adél, Bana Péter, Hegedűs Marica, Simon Fruzsina ; ill. Ziegenheim Szilveszter, MKE Fiatal Kémikusok Fóruma, S. l., 45, 2021.

DEA

13.

Gyuricza, B., Péli-Szabó, J., Arató, V. Z., Szűcs, D., Vágner, A., Szikra, D. P., Fekete, A.: Synthesis of Novel, Dual-Targeting 68Ga-NODAGA-LacN-E[c(RGDfK)]2 Glycopeptide as a PET Imaging Agent for Cancer Diagnosis.
Pharmaceutics. 13 (6), 1-13, 2021.

doi DEA WoS Scopus

Journal metrics:

Q1 Pharmaceutical Science

14.

Ghiani, S., Hawala, I., Szikra, D. P., Trencsényi, G., Baranyai, Z., Nagy, G., Vágner, A., Stefania, R., Pandey, S., Maiocchi, A.: Synthesis, radiolabeling, and pre-clinical evaluation of [44Sc]Sc-AAZTA conjugate PSMA inhibitor, a new tracer for high-efficiency imaging of prostate cancer.
Eur. J. Nucl. Med. Mol. Imaging. 48 (8), 2351-2362, 2021.

doi DEA WoS Scopus

Journal metrics:

D1 Medicine (miscellaneous)

D1 Radiology, Nuclear Medicine and Imaging

15.

Guidolin, N., Travagin, F., Giovenzana, G. B., Vágner, A., Lotti, S., Chianale, F., Brücher, E., Maisano, F., Kirchin, M. A., Tedoldi, F., Giorgini, A., Serra, S. C., Baranyai, Z.: Interaction of macrocyclic gadolinium-based MR contrast agents with Type I collagen. Equilibrium and kinetic studies.
Dalton Trans. 49 (42), 14863-14870, 2020.

doi DEA WoS Scopus

Journal metrics:

Q1 Inorganic Chemistry

16.

Kis, A., Péli-Szabó, J., Dénes, N., Vágner, A., Nagy, G., Garai, I., Fekete, A., Szikra, D. P., Hajdu, I., Matolay, O., Méhes, G., Mező, G., Kertész, I., Trencsényi, G.: In vivo Imaging of Hypoxia and Neoangiogenesis in Experimental Syngeneic Hepatocellular Carcinoma Tumor Model Using Positron Emission Tomography.
Biomed Res. Int. 2020, 1-10, (article identifier: 4952372), 2020.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q2 Immunology and Microbiology (miscellaneous)

Q2 Medicine (miscellaneous)

17.

Szikra, D. P., Forgács, V., Nagy, G., Vágner, A., Fekete, A., Trencsényi, G.: Development of a solid target system.
Eur. J. Nucl. Med. Mol. Imaging. 46 (1), S721-S722, 2019.

doi DEA WoS

18.

Farkas, E., Vágner, A., Negri, R., Lattuada, L., Tóth, I., Colombo, V., Esteban-Gómez, D., Platas-Iglesias, C., Notni, J., Baranyai, Z., Giovenzana, G. B.: PIDAZTA: Structurally Constrained Chelators for the Efficient Formation of Stable Gallium-68 Complexes at Physiological pH.
Chem.-Eur. J. 25, 1-13, 2019.

doi DEA WoS Scopus

Journal metrics:

Q1 Catalysis

D1 Chemistry (miscellaneous)

D1 Organic Chemistry

19.

Vágner, A., Forgács, A., Brücher, E., Tóth, I., Maiocchi, A., Wurzer, A., Wester, H. J., Notni, J., Baranyai, Z.: Equilibrium Thermodynamics, Formation, and Dissociation Kinetics of Trivalent Iron and Gallium Complexes of Triazacyclononane-Triphosphinate (TRAP) Chelators: Unraveling the Foundations of Highly Selective Ga-68 Labeling.
Front. Chem. 6, 1-12, 2018.

doi DEA WoS Scopus

Journal metrics:

Q1 Chemistry (miscellaneous)

20.

Wurzer, A., Vágner, A., Horváth, D., Fellegi, F., Wester, H. J., Kálmán, F. K., Notni, J.: Synthesis of Symmetrical Tetrameric Conjugates of the Radiolanthanide Chelator DOTPI for Application in Endoradiotherapy by Means of Click Chemistry.
Front. Chem. 6, 1-11, 2018.

doi DEA WoS Scopus

Journal metrics:

Q1 Chemistry (miscellaneous)

21.

Vágner, A., D'Alessandria,, C., Gambino, G., Schwaiger, M., Aime, S., Maiocchi, A., Tóth, I., Baranyai, Z., Tei, L.: A rigidified AAZTA-like ligand as efficient chelator for 68Ga radiopharmaceuticals.
ChemistrySelect. 1 (2), 163-171, 2016.

doi DEA

22.

Giani, A. M., Vágner, A., Negri, R., Baranyai, Z., Giovenzana, G. B.: cis-IPDTA: an original polyaminopolycarboxylic chelating agent from isophoronediamine: Synthesis and thermodynamic characterization of metal complexes.
Polyhedron. 109, 115-119, 2016.

doi DEA WoS Scopus

Journal metrics:

Q3 Inorganic Chemistry

Q2 Materials Chemistry

Q3 Physical and Theoretical Chemistry

23.

Vágner, A., Gianolio, E., Aime, S., Maiocchi, A., Tóth, I., Baranyai, Z., Tei, L.: High kinetic inertness of a bis-hydrated Gd-complex with a constrained AAZTA-like ligand.
Chem. Commun. 52 (75), 11235-11238, 2016.

doi DEA

Journal metrics:

Q1 Catalysis

D1 Ceramics and Composites

D1 Chemistry (miscellaneous)

D1 Electronic, Optical and Magnetic Materials

D1 Materials Chemistry

D1 Metals and Alloys

D1 Surfaces, Coatings and Films

24.

Baranyai, Z., Reich, D., Vágner, A., Weineisen, M., Tóth, I., Wester, H. J., Notni, J.: A shortcut to high-affinity Ga-68 and Cu-64 radiopharmaceuticals: one-pot click chemistry trimerisation on the TRAP platform.
Dalton Trans. 44 (24), 11137-11146, 2015.

doi DEA

Journal metrics:

Q1 Inorganic Chemistry

25.

Tei, L., Baranyai, Z., Gaino, L., Forgács, A., Vágner, A., Botta, M.: Thermodynamic stability, kinetic inertness and relaxometric properties of monoamide derivatives of lanthanide(III) DOTA complexes.
Dalton Trans. 44 (12), 5467-5478, 2015.

doi DEA

Journal metrics:

Q1 Inorganic Chemistry

Vágner Adrienn

Publication list